학술논문
Not COVID-19, Don’t Overlook Pneumocystis in Patients on Gefitinib!
Document Type
article
Source
Current Oncology, Vol 28, Iss 1, Pp 961-964 (2021)
Subject
Language
English
ISSN
28010094
1718-7729
1198-0052
62208209
1718-7729
1198-0052
62208209
Abstract
An 82-year-old woman treated for advanced lung cancer with gefitinb was admitted to the emergency unit complaining of dyspnea. Chest computed tomography found abnormalities classified as possible diffuse COVID-19 pneumonia. RT-PCR for Sars-Cov-2 was twice negative. PCR for Pneumocystis jirovecii was positive on bronchoalveolar lavage. The final diagnosis was Pneumocystis jirovecii pneumonia. Therefore, physicians must be careful not to misdiagnose COVID-19, especially in cancer patients on small-molecule therapeutics like gefitinib and corticosteroids.